Alumni raised $1.45B in 2022 - Download Free Report Now

BioLineRx (TASE: BLRX)

Injectable biopolymer for the direct treatment of acute myocardial infarction (AMI).

Start Free Trial
Claim Company Profile

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of BioLineRx (TASE: BLRX) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About BioLineRx (TASE: BLRX)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Companies We Work With

  • 0-Minnetronix.jpg
  • 1-jnj.png
  • 2-medtronic.png
  • 3-abbott.png
  • 4-baxter.png
  • 7-bostonscientific.png
  • 8-bd.png
  • 9-smithnephew.png
  • 10-stryker.png
  • 33m.png
  • allergan.jpg
  • bain.jpg
  • bbraun.png
  • beckmancoulter.png
  • cardinal.png
  • depuysynthes.png
  • drager.png
  • edwardslifesciences.png
  • ethicon.png
  • ge.png
  • gore.png
  • hospira.png
  • jlabs.jpg
  • kimberlyclark.png
  • merck.jpg
  • olympus.png
  • orthofix.png
  • philips.png
  • sanofigenzyme.png
  • teleflex.jpg
  • terumo.png
  • zimmerbiomet.png